Your browser doesn't support javascript.
loading
The value of prospective metabolomic susceptibility endotypes: broad applicability for infectious diseases.
Chen, Yulu; Mendez, Kevin; Begum, Sofina; Dean, Emily; Chatelaine, Haley; Braisted, John; Fangal, Vrushali D; Cote, Margaret; Huang, Mengna; Chu, Su H; Stav, Meryl; Chen, Qingwen; Prince, Nicole; Kelly, Rachel; Christopher, Kenneth B; Diray-Arce, Joann; Mathé, Ewy A; Lasky-Su, Jessica.
Affiliation
  • Chen Y; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Mendez K; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Begum S; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Dean E; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Chatelaine H; Division of Preclinical Innovation, National Center for Advancing Translational Science, National Institutes of Health, Rockville, MD, USA.
  • Braisted J; Division of Preclinical Innovation, National Center for Advancing Translational Science, National Institutes of Health, Rockville, MD, USA.
  • Fangal VD; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Cote M; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Huang M; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Chu SH; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Stav M; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Chen Q; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Prince N; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Kelly R; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Christopher KB; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Division of Renal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Diray-Arce J; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
  • Mathé EA; Division of Preclinical Innovation, National Center for Advancing Translational Science, National Institutes of Health, Rockville, MD, USA. Electronic address: ewy.mathe@nih.gov.
  • Lasky-Su J; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: rejas@channing.harvard.edu.
EBioMedicine ; 96: 104791, 2023 Oct.
Article de En | MEDLINE | ID: mdl-37734204
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies transmissibles / Grippe humaine / COVID-19 Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: EBioMedicine Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies transmissibles / Grippe humaine / COVID-19 Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: EBioMedicine Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique